Evidence map›Paper›PMID 36494468›Full record

ArticleScientific reports2022

Engineered human organ-specific urethra as a functional substitute.

Christophe Caneparo, Stéphane Chabaud, Julie Fradette, Stéphane Bolduc

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Description of the Human Penile Urethra Epithelium.Medicina (Kaunas, Lithuania) · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Tissue Engineering for Penile Reconstruction.Bioengineering (Basel, Switzerland) · 2024
    Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Christophe CaneparoLOEX/Regenerative Medicine Division, CHU de Québec-Université Laval Research Center, Hôpital Enfant-Jésus, 1401, 18E Rue, Quebec, QC, G1J 1Z4, Canada.
Stéphane ChabaudLOEX/Regenerative Medicine Division, CHU de Québec-Université Laval Research Center, Hôpital Enfant-Jésus, 1401, 18E Rue, Quebec, QC, G1J 1Z4, Canada.
Julie FradetteLOEX/Regenerative Medicine Division, CHU de Québec-Université Laval Research Center, Hôpital Enfant-Jésus, 1401, 18E Rue, Quebec, QC, G1J 1Z4, Canada.
Stéphane BolducLOEX/Regenerative Medicine Division, CHU de Québec-Université Laval Research Center, Hôpital Enfant-Jésus, 1401, 18E Rue, Quebec, QC, G1J 1Z4, Canada. stephane.bolduc@fmed.ulaval.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Urologic patients may be affected by pathologies requiring surgical reconstruction to re-establish a normal function. The lack of autologous tissues to reconstruct the urethra led clinicians toward new solutions, such as tissue engineering. Tridimensional tissues were produced and characterized from a clinical perspective. The balance was optimized between increasing the mechanical resistance of urethral-engineered tissue and preserving the urothelium's barrier function, essential to avoid urine extravasation and subsequent inflammation and fibrosis. The substitutes produced using a mix of vesical (VF) and dermal fibroblasts (DF) in either 90%:10% or 80%:20% showed mechanical resistance values comparable to human native bladder tissue while maintaining functionality. The presence of mature urothelium markers such as uroplakins and tight junctions were documented. All substitutes showed similar histological features except for the noticeable decrease in polysaccharide globules for the substitutes made with a higher proportion of DF. The degree of maturation evaluated with electron microscopy was positively correlated with the increased concentration of VF in the stroma. Substitutes produced with VF and at least 10% of DF showed sufficient mechanical resistance to withstand surgeon manipulation and high functionality, which may improve long-term patients' quality of life, representing a great future alternative to current treatments.

Indexed as

Quality of LifeUrethraHumansTissue EngineeringUroplakinsUrotheliumUroplakins

Identifiers

PMID36494468
PMCPMC9734558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.